Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1

ClinicalTrials.gov ID: NCT06948435

Public ClinicalTrials.gov record NCT06948435. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 12:03 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Once Daily in Participants With Hypertension and Obesity or Overweight: Randomized, Double-Blind, Placebo-Controlled Trials (ATTAIN-HYPERTENSION)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

GZL1 is an independent study conducted under the GZPL master protocol. GZL1 will evaluate the efficacy and safety of orforglipron for treatment of hypertension in participants with obesity or overweight.

Study identification

NCT ID
NCT06948435
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
487 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2025 (Actual)
Primary completion
Sep 2027 (Estimated)
Completion
Sep 2027 (Estimated)
Last update posted
May 29, 2026

2025 – 2027

United States locations

U.S. sites
28
U.S. states
18
U.S. cities
27
Facility City State ZIP Site status
Elite Clinical Studies, LLC Phoenix Arizona 85018 —
Valley Clinical Trials, Inc. Covina California 91723 —
Valley Clinical Trials, Inc. Northridge California 91325 —
Chase Medical Research, LLC Waterbury Connecticut 06708 —
Excel Medical Clinical Trials Boca Raton Florida 33434 —
Care Access - Brandon Brandon Florida 33510 —
Northeast Research Institute - Downtown Office Jacksonville Florida 32204 —
Peace River Cardiovascular Center Port Charlotte Florida 33952 —
East-West Medical Research Institute Honolulu Hawaii 96814 —
Ascension Saint Agnes Heart Care Baltimore Maryland 21229 —
Lucida Clinical Trials New Bedford Massachusetts 02740 —
Arcturus Healthcare , PLC, Troy Internal Medicine Research Division Troy Michigan 48098 —
StudyMetrix Research City of Saint Peters Missouri 63303 —
Excel Clinical Research, LLC Las Vegas Nevada 89109 —
Palm Research Center Sunset Las Vegas Nevada 89148 —
Rochester Clinical Research, LLC Rochester New York 14609 —
Remington-Davis, Inc Columbus Ohio 43215 —
PriMED Clinical Research Dayton Ohio 45429 —
Advanced Research Institute - Tigard Tigard Oregon 97223 —
Care Access - Mauldin Mauldin South Carolina 29662 —
Dallas Heart and Vascular Consultants, PA Duncanville Texas 75137 —
Texas Institute of Cardiology, PA McKinney Texas 75071 —
North Hills Family Medicine/North Hills Medical Research North Richland Hills Texas 76180 —
Advanced Research Institute Ogden Utah 84405 —
Carient Heart & Vascular - Manassas Manassas Virginia 20109 —
Health Research of Hampton Roads, Inc. Newport News Virginia 23606 —
National Clinical Research, Inc Richmond Virginia 23294 —
Eastside Research Associates Redmond Washington 98052 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 71 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06948435, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 29, 2026 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06948435 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →